PACS Group, Inc. (NYSE:PACS – Get Free Report) CEO Jason Murray sold 20,173 shares of the company’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $42.56, for a total value of $858,562.88. Following the completion of the sale, the chief executive officer directly owned 54,626,753 shares of the company’s stock, valued at approximately $2,324,914,607.68. This trade represents a 0.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jason Hulse Murray also recently made the following trade(s):
- On Wednesday, September 2nd, Jason Murray sold 23,783 shares of PACS Group stock. The stock was sold at an average price of $42.94, for a total transaction of $1,021,242.02.
- On Tuesday, September 1st, Jason Murray sold 24,157 shares of PACS Group stock. The stock was sold at an average price of $42.39, for a total transaction of $1,024,015.23.
- On Friday, August 21st, Jason Murray sold 59,244 shares of PACS Group stock. The stock was sold at an average price of $43.90, for a total value of $2,600,811.60.
- On Thursday, August 20th, Jason Murray sold 91,306 shares of PACS Group stock. The stock was sold at an average price of $43.92, for a total value of $4,010,159.52.
- On Wednesday, August 19th, Jason Murray sold 84,717 shares of PACS Group stock. The shares were sold at an average price of $44.26, for a total transaction of $3,749,574.42.
- On Tuesday, August 18th, Jason Murray sold 66,797 shares of PACS Group stock. The stock was sold at an average price of $44.18, for a total transaction of $2,951,091.46.
- On Monday, August 17th, Jason Murray sold 84,602 shares of PACS Group stock. The shares were sold at an average price of $44.16, for a total transaction of $3,736,024.32.
PACS Group Price Performance
Shares of PACS opened at $43.04 on Friday. PACS Group, Inc. has a twelve month low of $7.50 and a twelve month high of $49.49. The stock’s 50 day moving average is $44.65 and its two-hundred day moving average is $38.89. The firm has a market capitalization of $6.81 billion, a PE ratio of 25.02, a P/E/G ratio of 1.22 and a beta of -0.13. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21.
Institutional Investors Weigh In On PACS Group
A number of large investors have recently bought and sold shares of PACS. Vanguard Group Inc. increased its position in PACS Group by 14.4% during the fourth quarter. Vanguard Group Inc. now owns 4,506,227 shares of the company’s stock worth $172,994,000 after buying an additional 566,502 shares in the last quarter. Alyeska Investment Group L.P. lifted its position in shares of PACS Group by 159.5% in the fourth quarter. Alyeska Investment Group L.P. now owns 2,250,007 shares of the company’s stock valued at $86,378,000 after acquiring an additional 1,382,984 shares in the last quarter. California State Teachers Retirement System boosted its stake in shares of PACS Group by 3,298.3% during the second quarter. California State Teachers Retirement System now owns 1,917,094 shares of the company’s stock valued at $81,745,000 after acquiring an additional 1,860,680 shares during the last quarter. Balyasny Asset Management L.P. boosted its stake in shares of PACS Group by 67.3% during the third quarter. Balyasny Asset Management L.P. now owns 1,356,240 shares of the company’s stock valued at $18,621,000 after acquiring an additional 545,348 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its position in PACS Group by 19.6% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,350,551 shares of the company’s stock worth $18,543,000 after purchasing an additional 220,939 shares in the last quarter.
Wall Street Analyst Weigh In
PACS has been the subject of several research analyst reports. UBS Group increased their price objective on PACS Group from $57.00 to $60.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Truist Financial set a $62.00 price target on shares of PACS Group in a research note on Wednesday. Zacks Research raised shares of PACS Group from a “hold” rating to a “strong-buy” rating in a research note on Monday, August 10th. Wall Street Zen downgraded shares of PACS Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 8th. Finally, Royal Bank Of Canada lifted their price target on shares of PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research report on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, PACS Group presently has an average rating of “Buy” and a consensus target price of $56.00.
View Our Latest Report on PACS Group
Key Stories Impacting PACS Group
Here are the key news stories impacting PACS Group this week:
- Positive Sentiment: Florida expansion adds significant scale. PACS plans to acquire operations of 32 nursing facilities in Florida, giving the company a new regional presence and potentially expanding revenue and operating synergies. PACS Group To Acquire Operations Of 32 Florida Facilities
- Positive Sentiment: Eduro transaction advances. PACS has closed on 31 of 34 Eduro buildings, while the remaining facilities are expected to be addressed separately. The completed transactions increase PACS’s operating footprint and support its acquisition-led growth strategy. PACS Group to enter Florida with 32 facilities; closes on 31 of 34 Eduro buildings
- Positive Sentiment: Analyst commentary was supportive. UBS said the Florida deal supports PACS’s broader market-expansion strategy, reinforcing the view that the transaction could improve the company’s long-term growth prospects. PACS’ Florida Deal Supports Market Expansion, UBS Says
- Neutral Sentiment: CEO Jason Murray sold shares under a preset plan. Murray sold a combined 68,113 PACS shares for approximately $2.90 million across September 1–3. The sales reduced his ownership by only about 0.12%; because they were executed under a pre-arranged Rule 10b5-1 plan, they provide limited evidence of a change in his outlook. He continues to own roughly 54.6 million shares. PACS CEO Form 4 filing
About PACS Group
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Featured Stories
- Five stocks we like better than PACS Group
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
